Table 1.
The annual consumption of carbapenems (DDD/1000 patient-days) from 2007–2013.
| Carbapenems Consumption (DDD/1000 Patient-Days) | |||||||
|---|---|---|---|---|---|---|---|
| Year | Meropenem | Imipenem | Doripenem | Ertapenem | Gr1 | Gr2 | Total |
| 2007 # | 23.23 | 12.42 | 0 | 1.75 | 1.75 | 35.65 | 37.40 |
| 2008 | 37.19 | 1.81 | 0.29 | 2.35 | 2.35 | 39.29 | 41.64 |
| 2009 | 25.36 | 1.59 | 5.44 | 3.86 | 3.86 | 32.39 | 36.25 |
| 2010 | 13.56 | 3.21 | 1.47 | 7.39 | 7.39 | 18.24 | 25.63 |
| 2011 | 20.28 | 3.9 | 0 | 13.57 | 13.57 | 24.18 | 37.75 |
| 2012 | 19.67 | 3.02 | 0 | 12.67 | 12.67 | 22.69 | 35.36 |
| 2013 | 15.27 | 3.73 | 0 | 17.36 | 17.36 | 19.00 | 36.36 |
| r | −0.63 a | −0.44 b | −0.23 b | 0.97 a | 0.97 a | −0.84 a | −0.22 a |
| p value | 0.129 | 0.319 | 0.620 | 0.000 ** | 0.000 ** | 0.018 * | 0.631 |
# the carbapenem consumption was collected for 11 months; a, statistic calculation was based on the Pearson’s correlation coefficient; b, statistic calculation was based on the Spearman’s correlation coefficient; * Correlation is significant at the 0.05 level (2-tailed); ** Correlation is significant at the 0.01 level (2-tailed).